Mission changes, shuttering lab to focus on clinical assets
AbbVie-partnered Mission Therapeutics is tweaking its trajectory, closing a preclinical laboratory in the U.K. to focus on its two clinical candidates.
AbbVie-partnered Mission Therapeutics is tweaking its trajectory, closing a preclinical laboratory in the U.K. to focus on its two clinical candidates.
